Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shu-Zhi Zang

In Silico Insight Into EGFR Treatment in Patients With Lung Carcinoma and T790M Mutations

Experimental and Therapeutic Medicine

English

Related publications

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery

Oncology

2014

English

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

Journal of Thoracic Oncology

English

C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans or in Separate Clones?

Journal of Thoracic Oncology

English

EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Annals of Surgical Oncology

Oncology

Surgery

2017

English

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2015

English

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors

English

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma With G719S, S768I, and T790M Mutations

Internal Medicine

Medicine

2018

English

EGFR With TKI-sensitive Mutations in Exon 19 Is Highly Expressed and Frequently Detected in Chinese Patients With Lung Squamous Carcinoma

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shu-Zhi Zang

In Silico Insight Into EGFR Treatment in Patients With Lung Carcinoma and T790M Mutations

Related publications

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans or in Separate Clones?

EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma With G719S, S768I, and T790M Mutations

EGFR With TKI-sensitive Mutations in Exon 19 Is Highly Expressed and Frequently Detected in Chinese Patients With Lung Squamous Carcinoma